Related Experiment Video
Updated: Jul 18, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
[Uniform programme in caring for patients with acute hepatic porphyria]
E Kostrzewska1, A Gregor, A Lipniacki
1Poradnia i Pracownia Badań nad Porfiria Instytutu Hematologii i Transfuzjologii w Warszawie.
A Ministry of Health program improved porphyria diagnosis and prophylaxis in Poland. This initiative reduced severe attacks and mortality, though regional centers require further funding.
Area of Science:
- Medical Science
- Public Health
- Genetics
Context:
- The Ministry of Health commissioned a comprehensive program to address porphyria in Poland.
- Data from 1996-1998 formed the basis for program development and evaluation.
- Porphyria diagnosis and management presented significant public health challenges.
Purpose:
- To enhance the early diagnosis, treatment, and prophylaxis of porphyria.
- To disseminate crucial information on porphyria to healthcare professionals and patients.
- To establish accessible diagnostic methods and safe treatment guidelines.
Summary:
- A booklet detailing porphyria diagnosis, treatment, and prophylaxis was distributed nationwide.
- Simple diagnostic methods were introduced to hospital laboratories for early detection.
- Lectures and publications aimed to educate medical staff and advance scientific understanding.
Impact:
- Significant improvement in early clinical diagnosis and family prophylaxis of porphyria.
- Reduction in the frequency of severe porphyria attacks and mortality rates.
- Demonstrated the need for sustained financial support for regional diagnostic centers.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Jaundice

